Skip to main content

Table 2 Impact of adequate antiviral treatment on overall IBD complications in CMV group

From: Adequate antiviral treatment lowers overall complications of cytomegalovirus colitis among inpatients with inflammatory bowel diseases

 

IBD + CMV (n = 42)

P

 

CD + CMV (n = 11)

P

 

UC + CMV (n = 31)

P

Antiviral

treatment

Adequate (n = 24)

Inadequate (n = 18)

  

Adequate (n = 5)

Inadequate (n = 6)

  

Adequate (n = 19)

Inadequate (n = 12)

 

Overall IBD complications

7 (29.2%)

13 (72.2%)

0.006*

 

1 (20%)

6 (100%)

0.015*

 

6 (31.6%)

7 (58.3%)

0.141

  1. Adequate antiviral treatment: intravenous ganciclovir and/or oral valganciclovir for at least 14 days. Overall, the IBD complications included strictures, abscesses, fistulas, colon cancer, and IBD-related surgeries. Abbreviations: CD, Crohn’s disease; CMV, cytomegalovirus; IBD, inflammatory bowel disease; UC, ulcerative colitis; WBC, white blood cell; * P < 0.05, calculated using the Chi-square or Fisher’s exact test